Task: Answer the multiple choice question.
Question: Which drug exhibits a -33.060% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCn1c(-c2ccccc2O)n[nH]c1=S
b.) C/C(CC(=O)NCc1ccc(Cl)cc1)=N\NC(=O)COc1ccc(C)cc1Br
Answer: b. C/C(CC(=O)NCc1ccc(Cl)cc1)=N\NC(=O)COc1ccc(C)cc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(CC(=O)NCc1ccc(Cl)cc1)=N\NC(=O)COc1ccc(C)cc1Br
C/C(CC(=O)NCc1ccc(Cl)cc1)=N\NC(=O)COc1ccc(C)cc1Br
(3E)-3-[[2-(2-bromo-4-methylphenoxy)acetyl]hydrazinylidene]-N-[(4-chlorophenyl)methyl]butanamide